Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea · Delayed Price · Currency is KRW 5,490.00
-30.00 (-0.54%)
At close: Sep 15, 2025
Wonbiogen Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 5,840 | 5,690 | 5,497 | 3,206 | -716.2 | -11,662 |
Depreciation & Amortization | 1,599 | 1,647 | 1,569 | 1,199 | 881.58 | 731.27 |
Loss (Gain) From Sale of Assets | - | 1.38 | 7.13 | -11.69 | 57.7 | - |
Asset Writedown & Restructuring Costs | 196.65 | 196.65 | - | - | - | - |
Loss (Gain) From Sale of Investments | 32.64 | 32.64 | -48.67 | 200 | - | - |
Loss (Gain) on Equity Investments | -39.32 | -42.83 | 60.51 | - | - | - |
Stock-Based Compensation | - | - | - | - | 8.11 | 18.07 |
Provision & Write-off of Bad Debts | -155.01 | -147.54 | 246.2 | 408.88 | 524.98 | 3.65 |
Other Operating Activities | -472.4 | -471.27 | 938.55 | 1,960 | 2,641 | 13,632 |
Change in Accounts Receivable | -314.21 | 197.36 | -2,521 | -224.68 | -256.06 | -1,754 |
Change in Inventory | 159.23 | 1,540 | -1,215 | -936.87 | -2,361 | -221.81 |
Change in Accounts Payable | 970.44 | 207.79 | 452.82 | -133.58 | 741.99 | -38.82 |
Change in Unearned Revenue | -6.07 | 2.24 | 23.12 | -46.45 | 16.16 | - |
Change in Income Taxes | - | - | - | - | 31.85 | - |
Change in Other Net Operating Assets | 14.67 | -3.47 | -175.27 | 161.35 | -487.8 | 89.31 |
Operating Cash Flow | 7,825 | 8,850 | 4,835 | 5,782 | 1,082 | 798.06 |
Operating Cash Flow Growth | 29.30% | 83.02% | -16.38% | 434.37% | 35.58% | - |
Capital Expenditures | -798.06 | -648.41 | -1,646 | -6,494 | -2,336 | -679.28 |
Sale of Property, Plant & Equipment | - | 0.4 | 121.73 | 0.12 | 1,050 | - |
Sale (Purchase) of Intangibles | -34.58 | -16.22 | -88.39 | -74.16 | -1.96 | -12.57 |
Investment in Securities | 1,097 | 3,002 | -775.82 | 723.24 | -1,098 | -40.52 |
Other Investing Activities | -12.69 | -4 | 22.14 | -6.78 | -95.43 | -0.45 |
Investing Cash Flow | 345.62 | 2,427 | -2,589 | -5,852 | -2,481 | -732.82 |
Short-Term Debt Issued | - | - | 500 | 59.89 | - | 1,000 |
Long-Term Debt Issued | - | - | 500 | - | 7,984 | 20 |
Total Debt Issued | - | - | 1,000 | 59.89 | 7,984 | 1,020 |
Short-Term Debt Repaid | - | -500 | -500 | -59.89 | -1,420 | - |
Long-Term Debt Repaid | - | -5,966 | -2,797 | -303.66 | -240.47 | -1,038 |
Total Debt Repaid | -5,919 | -6,466 | -3,297 | -363.55 | -1,660 | -1,038 |
Net Debt Issued (Repaid) | -5,919 | -6,466 | -2,297 | -303.66 | 6,324 | -17.92 |
Issuance of Common Stock | - | - | 218.33 | - | 411.26 | - |
Repurchase of Common Stock | -7.57 | - | - | -2,996 | - | - |
Dividends Paid | -709.19 | -709.19 | -349.55 | - | - | - |
Other Financing Activities | -10 | -10 | -1.32 | -1,000 | -163.81 | 10 |
Financing Cash Flow | -6,646 | -7,186 | -2,429 | -4,300 | 6,571 | -7.92 |
Foreign Exchange Rate Adjustments | -8.29 | 68 | -6.72 | -75.95 | 1.2 | -17.12 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 1,302 | - |
Net Cash Flow | 1,516 | 4,159 | -189.86 | -4,445 | 6,476 | 40.2 |
Free Cash Flow | 7,027 | 8,201 | 3,189 | -711.95 | -1,254 | 118.77 |
Free Cash Flow Growth | 55.79% | 157.16% | - | - | - | - |
Free Cash Flow Margin | 21.94% | 26.94% | 10.77% | -2.66% | -7.08% | 0.99% |
Free Cash Flow Per Share | 990.45 | 1155.96 | 419.31 | -98.94 | -180.51 | 25.56 |
Cash Interest Paid | 30.79 | 34.04 | 83.89 | 27.55 | 17.96 | -11.4 |
Cash Income Tax Paid | 1,215 | 1,375 | 1,041 | -55.27 | 222.5 | 602.46 |
Levered Free Cash Flow | 5,579 | 6,801 | 1,293 | -4,009 | -16,614 | - |
Unlevered Free Cash Flow | 5,610 | 6,837 | 1,366 | -3,213 | -16,345 | - |
Change in Working Capital | 824.06 | 1,944 | -3,435 | -1,180 | -2,315 | -1,925 |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.